ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Comparison of the Effectiveness of Once-Daily Alogliptin/Metformin and Twice-Daily Anagliptin/Metformin Combination Tablet in a Randomized, Parallel-Group, Open-Label Trial in Japanese Patients with Type 2 Diabetes.

Shunsuke Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.